Malignant Melanoma | Zendy

A. Ortega Candil | Zendy; Cristina Rodríguez Rey | Zendy; José Luis Carreras Delgado | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Malignant Melanoma

Author(s) -

A. Ortega Candil,

Cristina Rodríguez Rey,

José Luis Carreras Delgado

Publication year - 2012

Publication title -

isrn dermatology

Language(s) - English

Resource type - Journals

eISSN - 2090-4606

pISSN - 2090-4592

DOI - 10.5402/2012/308279

Subject(s) - medicine , melanoma , sentinel lymph node , positron emission tomography , radiology , biopsy , cancer staging , sentinel node , lymphatic system , lymph node , cancer , nuclear medicine , pathology , breast cancer , cancer research

Nuclear medicine plays an essential role in the correct staging of patients suffering from melanoma. Both sentinel lymph node biopsy (SLNB) and positron emission tomography (PET) represent its main diagnostic tools. SLNB is the choice procedure for lymphatic regional staging of these patients, including the result of this technique in the 2002 American Joint Cancer Committee melanoma staging. SLNB sensitivity is superior than PET/CT for the detection of lymphatic micrometastases in early stages of the disease. PET/CT is mainly used in confirming clinical metastases suspected, detection of recurrences, and recurrence restaging. PET/CT has also shown superiority against conventional diagnostic methods in the detection of distant metastases, being able to detect illness even six months earlier than those methods.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research